State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care
Medical Care Research and Review · 2023-08 · 80 (4) · 423-432
DOI: 10.1177/10775587231167514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Care Research and Review, online erschienen am 21.04.2023. Verfasst von Mark K Meiselbach und 8 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIMH NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
Provider networks in Medicaid Managed Care (MMC) play a crucial role in ensuring access to buprenorphine, a highly effective treatment for opioid use disorder. Using a difference-in-differences approach that compares network breadth across provider specialties and market segments within the same state, we investigated the association between three Medicaid policies and the breadth of MMC networks for buprenorphine prescribers: Medicaid expansion, substance use disorder (SUD) network adequacy criteria, and SUD carveouts. We found that both Medicaid expansion and SUD network adequacy criteria were associated with substantially increased breadth in buprenorphine-prescriber networks in MMC. In both cases, we found that the associations were largely driven by increases in the network breadth of primary care physician prescribers. Our findings suggest that Medicaid expansion and SUD network adequacy criteria may be effective strategies at states’ disposal to improve access to buprenorphine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Johns Hopkins University, Baltimore, MD, USA.
- University of Pittsburgh, PA, USA.
- Oregon Health & Science University, Portland, USA.
- RAND Corporation, Pittsburgh, PA, USA.
ORCID-Profile: Mark K Meiselbach, Coleman Drake, Daniel Polsky
Förderung
- NIDA NIH HHS
- NIMH NIH HHS
- National Institute of Mental Health
- National Institute on Drug Abuse
- Arnold Ventures
Zitieren
APA
Meiselbach, M. K., Drake, C., Zhu, J. M., Manibusan, B., Nagy, D., Sorbero, M. J., Saloner, B., Stein, B. D., & Polsky, D. (2023). State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care. Medical Care Research and Review, 80(4), 423-432. https://doi.org/10.1177/10775587231167514
Vancouver
Meiselbach MK, Drake C, Zhu JM, Manibusan B, Nagy D, Sorbero MJ, et al. State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care. Medical Care Research and Review. 2023;80(4):423-432. doi:10.1177/10775587231167514
BibTeX
@article{Meiselbach2023,
author = {Meiselbach, Mark K and Drake, Coleman and Zhu, Jane M and Manibusan, Brynna and Nagy, Dylan and Sorbero, Mark J and Saloner, Brendan and Stein, Bradley D and Polsky, Daniel},
title = {State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care},
journal = {Medical Care Research and Review},
year = {2023},
volume = {80},
number = {4},
pages = {423--432},
doi = {10.1177/10775587231167514}
}
EUVIMED